Yueyang Deng, Ph.D., is a Postdoctoral Fellow in the Department of Biomedical Engineering and the Rosalind & Morris Goodman Cancer Institute at McGill University, where she has held the position since 2023. She works in the Chen Lab under the supervision of Guojun Chen.
Her research focuses on bioresponsive nanomaterials and targeted immunotherapy approaches for cancer treatment, including work on lymph node immunoengineering and related nanoparticle technologies. She is the first author of the 2026 publication “Bioresponsive immunomodulator nanocomplex for selective immunoengineering in metastatic lymph nodes” in Proceedings of the National Academy of Sciences.